250 related articles for article (PubMed ID: 32899248)
1. Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling.
Cheon YH; Lee CH; Jeong DH; Kwak SC; Kim S; Lee MS; Kim JY
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899248
[TBL] [Abstract][Full Text] [Related]
2. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
3. Regulation of RANKL-induced osteoclastogenesis by RING finger protein RNF114.
Lin B; Ke Q; Leaman DW; Goel V; Agarwal A
J Orthop Res; 2018 Jan; 36(1):159-166. PubMed ID: 28708287
[TBL] [Abstract][Full Text] [Related]
4. Protective Effects of Fermented Oyster Extract against RANKL-Induced Osteoclastogenesis through Scavenging ROS Generation in RAW 264.7 Cells.
Jeong JW; Choi SH; Han MH; Kim GY; Park C; Hong SH; Lee BJ; Park EK; Kim SO; Leem SH; Jeon YJ; Choi YH
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30901917
[TBL] [Abstract][Full Text] [Related]
5. 2-Methoxystypandrone represses RANKL-mediated osteoclastogenesis by down-regulating formation of TRAF6-TAK1 signalling complexes.
Chiou WF; Liao JF; Huang CY; Chen CC
Br J Pharmacol; 2010 Sep; 161(2):321-35. PubMed ID: 20735418
[TBL] [Abstract][Full Text] [Related]
6. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
7. Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation.
Park JH; Lee NK; Lee SY
Mol Cells; 2017 Oct; 40(10):706-713. PubMed ID: 29047262
[TBL] [Abstract][Full Text] [Related]
8. RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.
Yao Z; Lei W; Duan R; Li Y; Luo L; Boyce BF
J Biol Chem; 2017 Jun; 292(24):10169-10179. PubMed ID: 28438834
[TBL] [Abstract][Full Text] [Related]
9. Picrasidine I from Picrasma Quassioides Suppresses Osteoclastogenesis via Inhibition of RANKL Induced Signaling Pathways and Attenuation of ROS Production.
Kong L; Wang B; Yang X; Guo H; Zhang K; Zhu Z; Liu J; Hao D
Cell Physiol Biochem; 2017; 43(4):1425-1435. PubMed ID: 29017159
[TBL] [Abstract][Full Text] [Related]
10. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation.
Lee NK; Choi YG; Baik JY; Han SY; Jeong DW; Bae YS; Kim N; Lee SY
Blood; 2005 Aug; 106(3):852-9. PubMed ID: 15817678
[TBL] [Abstract][Full Text] [Related]
11. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
12. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
[TBL] [Abstract][Full Text] [Related]
13. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.
Tran PT; Dat NT; Dang NH; Van Cuong P; Lee S; Hwangbo C; Van Minh C; Lee JH
Phytomedicine; 2019 Mar; 55():1-8. PubMed ID: 30668419
[TBL] [Abstract][Full Text] [Related]
14. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
Sundaram K; Nishimura R; Senn J; Youssef RF; London SD; Reddy SV
Exp Cell Res; 2007 Jan; 313(1):168-78. PubMed ID: 17084841
[TBL] [Abstract][Full Text] [Related]
15. Ormeloxifene inhibits osteoclast differentiation in parallel to downregulating RANKL-induced ROS generation and suppressing the activation of ERK and JNK in murine RAW264.7 cells.
Kharkwal G; Chandra V; Fatima I; Dwivedi A
J Mol Endocrinol; 2012 Jun; 48(3):261-70. PubMed ID: 22493142
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin E3 ligase Itch negatively regulates osteoclast formation by promoting deubiquitination of tumor necrosis factor (TNF) receptor-associated factor 6.
Zhang H; Wu C; Matesic LE; Li X; Wang Z; Boyce BF; Xing L
J Biol Chem; 2013 Aug; 288(31):22359-68. PubMed ID: 23782702
[TBL] [Abstract][Full Text] [Related]
17. RANKL-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis.
Kim MS; Yang YM; Son A; Tian YS; Lee SI; Kang SW; Muallem S; Shin DM
J Biol Chem; 2010 Mar; 285(10):6913-21. PubMed ID: 20048168
[TBL] [Abstract][Full Text] [Related]
18. 1α,25-(OH)
Yu C; Zhu Y; Lv X; Wang Y
In Vitro Cell Dev Biol Anim; 2021 Oct; 57(9):878-885. PubMed ID: 34780049
[TBL] [Abstract][Full Text] [Related]
19. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
20. BCL3 regulates RANKL-induced osteoclastogenesis by interacting with TRAF6 in bone marrow-derived macrophages.
Wang K; Li S; Gao Y; Feng X; Liu W; Luo R; Song Y; Ji Tu ; Liu Y; Yang C
Bone; 2018 Sep; 114():257-267. PubMed ID: 29933112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
